Interestingly, subunits of the GPI-T, such as PIG-U in mammals, as well as certain GPI-APs, have been recognized to be involved in the initial stages of tumor development and tumor progression and may be used as putative biomarkers for specific diagnosis, therapy and prognosis [48]. This evidence concerns the gene PIGU and neoplasm.